ENDO PHARMACEUTICALS HOLDINGS INC.
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 24, 2003 (July 24, 2003)

ENDO PHARMACEUTICALS HOLDINGS INC.

(Exact name of registrant as specified in its charter)
         
DELAWARE   01-15989   13-4022871
(State or other
jurisdiction of
incorporation)		   (Commission File Number)   (I.R.S. Employer
    Identification No.)
           
  100 Painters Drive
Chadds Ford, Pennsylvania		     19317  
  (Address of principal executive offices)     (Zip Code)

(610) 558-9800

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

TABLE OF CONTENTS

Item 7. Financial Statements and Exhibits
Item 9. Information Being Furnished Under Item 12
SIGNATURES
INDEX TO EXHIBITS
PRESS RELEASE

Table of Contents

Item 7.         Financial Statements and Exhibits.

(a)     Financial Statements of Business Acquired.

               Not applicable.

(b)     Pro Forma Financial Information.

               Not applicable.

(c)     Exhibits.

     
Exhibit Number   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated July 24, 2003

Item 9.        Information Being Furnished Under Item 12.

In accordance with Securities and Exchange Commission Release No. 33-8216, the following information, which is intended to be furnished under Item 12, “Results of Operational Financial Condition,” is instead being furnished under Item 9, “Regulation FD Disclosure.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.

On July 24, 2003, the Registrant issued an earnings release announcing its financial results for the quarter ended June 30, 2003. A copy of the earnings release is attached as Exhibit 99.1 and is incorporated herein by reference.

 

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

         
    ENDO PHARMACEUTICALS HOLDINGS INC.
    (Registrant)  
         
    By:   /s/ Carol A. Ammon
Name: Carol A. Ammon
Title:   Chairman & Chief Executive Officer

Dated:  July 24, 2003

 

Table of Contents

INDEX TO EXHIBITS

     
Exhibit No.   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated July 24, 2003